Abstract
TERMINAL differentiation and cell proliferation are in many cases, as in muscle cells1, mutually exclusive processes. While differentiating myoblasts are withdrawn from the cell cycle2, myogenesis is inhibited by some mitogens and overexpression of some oncogenes3,4, including proto-oncogene c-fos5 (which expresses a growth-associated protein constituting the regulatory factor AP-1 in conjunction with c-Jun6,7). MyoD, a muscle-specific transcription factor of the basic helix–loop–helix family8,9, acts at both levels because it triggers a muscle differentiation programme in non-muscle cells10–12, and induces a complete block of cell proliferation13,14. Antagonistic interaction between MyoD and c-Jun has been demonstrated15. We here show that c-fos expression greatly decreases upon muscle cell differentiation, concomitant with MyoD-induced activity. We have identified a MyoD-binding site overlapping with the serum-responsive element in the c-fos promoter. We demonstrate that MyoD can act as a negative regulator for c-fos transcription by blocking serum responsiveness through this binding site. These data suggest that the MyoD negative effect on cell growth could be partly mediated by transcriptional inactivation of growth-responsive genes.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Olson, E. N. et al. Molec. cell. Biochem. 104, 7–13 (1991).
Miller, J. B. Cell 69, 1–3 (1992).
Miner, J. H. & Wold, B. J. Molec. cell. Biol. 11, 2842–2851 (1991).
Grossi, M., Calconi, A. & Tato, F. Oncogene 6, 1767–1773 (1991).
Lassar, A. B., Thayer, M. J. Overell, R. W. & Weintraub, H. Cell 58, 659–667 (1989).
Chiu, R. et al. Cell 54, 541–552 (1988).
Sassone-Corsi, P., Ransone, L. J., Lamph, W. W. & Verma, I. M. Nature 336, 692–695 (1988).
Murre, M., McCaw, P. S. & Baltimore, D. Cell 56, 777–783 (1989).
Lassar, A. B. et al. Cell 58, 823–831 (1989).
Choi, J. et al. Proc. natn. Acad. Sci. U.S.A. 87, 7988–7992 (1990).
Davis, R. L., Weintraub, H. & Lassar, A. B. Cell 51, 987–1000 (1987).
Tapscott, S. J. et al. Science 242, 405–411 (1988).
Sorrentino, V., Pepperkok, R., Davis, R. L., Ansorge, W. & Philipson, L. Nature 345, 813–815 (1990).
Crescenzi, M., Fleming, T. P., Lassar, A. B., Weintraub, H. & Aaronson, S. A. Proc. natn. Acad. Sci. U.S.A. 87, 8442–8446 (1990).
Bengal, E. et al. Cell 68, 507–519 (1992).
Sun, X. H. & Baltimore, D. Cell 64, 459–470 (1991).
Metz, R. & Ziff, E. Oncogene 6, 2165–2178 (1991).
Treisman, R. Cell 46, 567–574 (1986).
Fisch, T. M., Prywes, R. & Roeder, R. G. Molec. cell. Biol. 7, 3490–3502 (1987).
Norman, C., Runswick, M., Pollock, R. & Treisman, R. Cell 55, 989–1003 (1988).
Shaw, P. E., Schröter, H. & Nordheim, A. Cell 56, 563–572 (1989).
Lassar, A. B. et al. Cell 66, 305–315 (1991).
Fisch, T. M., Prywes, R. & Roeder, R. G. Molec. cell. Biol. 9, 1327–1331 (1989).
Pollock, R. & Treisman, R. Genes Dev. 5, 2327–2341 (1991).
Leibovitch, M. P. et al. Expl Cell Res. 170, 80–92 (1987).
Trouche, D., Robin, P., Sassone-Corsi, P., Farrar, W. L. & Harel-Bellan, A. Blood 77, 55–63 (1991).
Pinset, C. et al. EMBO J. 10, 2411–2418 (1991).
Dignam, J. D., Lebowitz, R. M. & Roeder, R. G. Nucleic Acids Res. 11, 1474–1486 (1983).
Davis, R. L., Cheng, P. F., Lassar, A. B. & Weintraub, H. Cell 60, 733–746 (1990).
Trouche, D., Robin, P., Robillard, O., Sassone-Corsi, P. & Harel-Bellan, A. J. Immun. 147, 2398–2403 (1991).
Gorman, C. M., Moffat, L. F. & Howard, B. H. Molec. cell. Biol. 2, 1044–1051 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Trouche, D., Grigoriev, M., Lenormand, JL. et al. Repression of c-fos promoter by MyoD on muscle cell differentiation. Nature 363, 79–82 (1993). https://doi.org/10.1038/363079a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/363079a0
This article is cited by
-
EGR2 is a hub-gene in myocardial infarction and aggravates inflammation and apoptosis in hypoxia-induced cardiomyocytes
BMC Cardiovascular Disorders (2022)
-
Prolonged FOS activity disrupts a global myogenic transcriptional program by altering 3D chromatin architecture in primary muscle progenitor cells
Skeletal Muscle (2022)
-
Inhibition of the JNK/MAPK signaling pathway by myogenesis-associated miRNAs is required for skeletal muscle development
Cell Death & Differentiation (2018)
-
Signal-dependent fra-2 regulation in skeletal muscle reserve and satellite cells
Cell Death & Disease (2013)
-
Akt negatively regulates translation of the ternary complex factor Elk-1
Oncogene (2003)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.